Samsara BioCapital, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$643,000
-27.3%
40,5500.0%0.16%
-5.8%
Q4 2021$885,000
-27.0%
40,5500.0%0.17%
-9.5%
Q3 2021$1,212,000
-32.5%
40,5500.0%0.19%
-14.4%
Q2 2021$1,796,000
-36.5%
40,550
-36.4%
0.22%
-57.5%
Q1 2021$2,829,000
-19.1%
63,7700.0%0.52%
+48.3%
Q4 2020$3,497,000
+53.5%
63,770
-36.0%
0.35%
-44.6%
Q3 2020$2,278,000
-21.2%
99,643
-27.9%
0.64%
-31.7%
Q2 2020$2,892,000
+61.7%
138,197
+7.8%
0.93%
-9.6%
Q1 2020$1,788,000128,1971.03%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders